Stock DMAC DIAMEDICA THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions DiaMedica Therapeutics Inc.

Equities

DMAC

CA25253X2077

Delayed Nasdaq
Other stock markets
 01:32:56 2024-05-01 pm EDT 		5-day change 1st Jan Change
2.59 USD +2.37% Intraday chart for DiaMedica Therapeutics Inc. +5.71% -8.80%
Apr. 17 DiaMedica Therapeutics Launches Late-Stage Trial of Potential Stroke Treatment MT
Apr. 17 DiaMedica Therapeutics Inc. Announces First Patient Dosed in Relaunch of Its Pivotal Phase /3 ReMEDy2 Trial of DM199 for the Treatment of Acute Ischemic Stroke CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

  1. Stock Market
  2. Equities
  3. DMAC Stock
  4. Revisions DiaMedica Therapeutics Inc.